Mario Accardi, based in London, England, United Kingdom, is currently a CEO and Co-Founder at Orexia Therapeutics, bringing experience from previous roles at Global Genomics Group, Embody Orthopaedic, Orthonika and Inexia. Mario Accardi holds a 2016 - 2017 Postgraduate in Genomic Medicine @ Imperial College London. With a robust skill set that includes Customer Service, Financial Analysis, Sales, Microsoft Office, Business Strategy and more, Mario Accardi contributes valuable insights to the industry. Mario Accardi has 4 emails and 3 mobile phone numbers on RocketReach.